Pancreas transplantation for type 2 diabetes mellitus

Current Opinion in Organ Transplantation

Volumn 16, Issue 1, 2011, Pages 110-115

  Orlando, Giuseppe ^a,b   Stratta, Robert J ^a   Light, Jimmy ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

metabolic syndrome; obesity; pancreas transplantation; type 2 diabetes mellitus

Indexed keywords

C PEPTIDE;

ARTICLE; DISEASE CLASSIFICATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PANCREAS TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS TRANSPLANTATION; PATHOPHYSIOLOGY; PATIENT SELECTION; TREATMENT INDICATION;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; PANCREAS TRANSPLANTATION;

EID: 78751634993     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283424d1f     Document Type: Article

References (28)

1. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010; 33:73-77.
2. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetes Care 2005; 28:2289-2304.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32 (Suppl 1):S62-S67.
4. Wilkin TJ. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. Int J Obes (Lond) 2009; 33:716-726.
5. Service FJ, Rizza RA, Zimmerman BR, et al. The classification of diabetes by clinical and C-peptide criteria: a prospective population-based study. Diabetes Care 1997; 2:198-201.
6. Covic AMC, Schelling JR, Constantiner M, et al. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 2000; 58:1742-1750.
7. Esmatjes E, Fernandez C, Rueda S, et al. The utility of the C-peptide in the phenotyping of patient candidates for pancreas transplantation. Clin Transplant 2007; 21:358-362.
8. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996; 45:1289-1298.
9. Sener A, Cooper M, Bartlett ST. Is there a role for pancreas transplantation in type 2 diabetes mellitus? Transplantation 2010; 90:121-123.
10. Gruessner AC, Sutherland DER, Gruessner RWG. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant 2010; 15:93-101.
11. Gruessner AC, Sutherland DER. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2008:45-56.
12. Sasaki TM, Gray RS, Ratner RE, et al. Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 1998; 65:1510-1512.
13. Light JA, Sasaki TM, Currier CB, Barhyte DY. Successful long term kidneypancreas transplants regardless of C-peptide status and race. Transplantation 2001; 71:152-154.
14. Light JA, Barhyte DY. Simultaneous pancreas-kidney transplants in Type I and Type II diabetic patients with end-stage renal disease: similar 10-year outcomes. Transplant Proc 2008; 40:438-440.
15. Nath DS, Gruessner AC, Kandaswamy R, et al. Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant 2005; 19:792-797.
16. Singh RP, Rogers J, Farney AC, et al. Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation? Transplant Proc 2008; 40:510-512.
17. Chakkera HA, Bodner J, Heilman R, et al. Simultaneous kidney pancreas transplantation in select patients with type 2 diabetes mellitus having positive C-peptide and negative GAD-65 antibody. Xenotransplantation 2009; 16:308. (A IPITA-O-5.4).
18. Chakkera HA, Bodner JK, Heilman RL, et al. Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the Cpeptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc 2010; 42:2650-2652.
19. Ratner RE, Gray RS, Sasaki T, Light JA. Combined kidney-pancreas transplantation in patients with unrecognized NIDDM. Diabetologia 1996; 39 (Suppl. 1):A132. (A #500).
20. Stegall M, Wachs M, Kam I. Successful pancreas transplantation in adultonset diabetes mellitus (AODM). Diabetes 1997; 46 (s1):A64.
21. Pox C, Ritzel R, Busing M, et al. Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity. Exp Clin Endocrinol Diabetes 2002; 110:420-424.
22. Saudek F, Pruhova S, Boucek P, et al. Maturity-onset diabetes of the young with end-stage nephropathy: a new indication for simultaneous pancreas and kidney transplantation? Transplantation 2004; 77:1298-1300.
23. Friedman AL, Friedman EA. Pancreas transplantation for type 2 diabetes at U.S. transplant centers. Diabetes Care 2002; 25:1896.
24. Vistoli F, Croce C, Del Chiaro M, et al. Pancreas transplantation in selected type 2 diabetes mellitus recipients. Xenotransplantation 2009; 16:291. (A IPITA-O-1.5).
25. Margreiter C, Oberhuber R, Bonatti H, et al. Outcome of pancreas transplantation for type 2 diabetes mellitus. Am J Transplant 2010; 10 (Suppl. 4):550. (A #1803).
26. Sampaio M, Kuo HT, Poommipanit N, et al. Outcomes of type 2 diabetics submitted to simultaneous kidney pancreas transplant: an analysis of the OPTN/UNOS database. Am J Transplant 2010; 10 (Suppl. 4):112. (A #242).
27. Knight RJ, Lawless A, Patel SJ, et al. Simultaneous kidney-pancreas transplantation for ESRD patients with insulin-dependent diabetes and detectable C-peptide. Transplantation 2010; 90 (Suppl. 2):982. (A #2845).
28. Hau HM, Uhlmann D, Bartels M, Jonas S. Combined kidney-pancreas transplantation for patients with diabetes mellitus type II: a single center report. Transpl Int 2010; 23 (Suppl. 2):61. (A #0196).